Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in Europe

NCT01791361 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01791361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01791361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in Europe
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
September 19, 2012
Completion date
June 2, 2015
Enrollment
439 (actual)
Sites
84

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer